xbox高清视频线,国产精品偷伦视频免费观看了,中文字幕在线播放,亚瑟 中文字幕

關(guān)鍵詞:
  首頁 > 美迪醫(yī)訊 > 心臟:磁共振來預(yù)測治療成功  

心臟:磁共振來預(yù)測治療成功

【?2008-10-09 發(fā)布?】 美迪醫(yī)訊
美迪網(wǎng)領(lǐng)先的醫(yī)療器械電子商務(wù)平臺


研究人員開發(fā)了一種基于磁共振成像的新療法來探測和評估經(jīng)歷了心房顫動治療的患者在左心房壁上的傷害
心房顫動是一種反常的心跳節(jié)奏(心律失常)。目前有效的治療心房顫動的方法是射頻電流消融療法:用一種溫和的無痛的電流波來去掉經(jīng)過謹(jǐn)慎選擇的心臟肌肉細(xì)胞以此來阻止這些肌肉細(xì)胞傳導(dǎo)額外的心電刺激。
到目前為止,沒有一種準(zhǔn)確的非介入的辦法能夠用來準(zhǔn)確的評估左心房傷痕的情況,研究的負(fù)責(zé)人Nassir F. Marrouche談到,我們開發(fā)了一種新型的基于磁共振技術(shù)的方法來檢測和評估左心房傷痕的范圍并且潛在的來預(yù)測射頻電流消融療法是否成功。
這項研究的研究者們開發(fā)的一項不用介入的技術(shù),稱之為延時增強(qiáng)心血管磁共振,這項技術(shù)用來在患有心房顫動的患者左心房進(jìn)行射頻電流消融療法之前和之后創(chuàng)造3維圖像。這個傷害的組織重建模型能重建射頻電流消融療法中射頻能量所應(yīng)用到的相關(guān)區(qū)域,因此可以反映出組織上的傷痕。研究者們同樣發(fā)現(xiàn)左心房壁上手術(shù)后傷害比率低的患者更容易避免心律不齊,并建議在傷痕大小和手術(shù)是否成功之間建立聯(lián)系。
這個新成像技術(shù)和提供的分析可以幫助醫(yī)生改善射頻電流消融療法程序,使他更容易去識別哪些是需要去移除的心臟肌肉細(xì)胞。以及移除這些心臟肌肉細(xì)胞將可能減少在心房顫動復(fù)發(fā)的比率。
這項3維磁共振的益處在于它能呈現(xiàn)完整的左心房房壁,Marrouche談到,并且他是安全的和非介入所以它可以反復(fù)使用而對患者不會造成重大風(fēng)險

 

Heart: MRI to Predict Treatment Success
Researchers have developed a magnetic resonance imaging (MRI)-based method for detecting and quantifying injury to the wall of the heart’s left atrium in patients who have undergone a procedure to treat atrial fibrillation.
Atrial fibrillation (AF) is an abnormal heart rhythm. One effective method of treating AF is radiofrequency (RF) ablation. In RF ablation, mild, painless radiofrequency energy is used to destroy carefully selected heart muscle cells to stop them from conducting extra electrical impulses. Previous research suggested scar formation within the left atrium (LA) after RF ablation helps to predict the success of the procedure in preventing the recurrence of atrial fibrillation.
“Until now, there has not been an accurate, non-invasive way to assess LA scar formation,” said lead author Nassir F. Marrouche. “We have developed a novel MRI-based method to detect and measure the extent of LA wall scarring and, potentially, predict the success of RF ablation.”
The scientists developed a technique for using a non-invasive method called delayed-enhancement cardiovascular MRI (DE-CMRI) to create 3-D images of the left atrium both before and after RF ablation in patients with atrial fibrillation. They processed and analysed these images using custom software tools and then used computer algorithms to calculate the extent of LA wall injury.
The team found that all patients who underwent RF ablation showed evidence of left atrium wall injury on MRI three months after the procedure. The pattern of tissue injury correlated with the areas where the radiofrequency energy was applied during RF ablation, and thus, was presumed to reflect tissue scarring. The scientists also found patients with a higher percentage of LA wall injury were more likely to be free of arrhythmia than patients with lower percentages, suggesting the degree of scarring is linked to the likelihood of success in the RF ablation procedure.
The novel visualisation technique and analysis potentially could help doctors improve planning for RF ablation procedures by making it easier to identify the heart muscle cells that need to be destroyed. Improved localisation and isolation of these heart muscle cells would likely lead to a reduction in the recurrence rate of AF.
“The benefit of 3-D MRI is that it visualises the entire LA wall,” said Marrouche. “And, it is safe and non-invasive, so it can be repeated without significant risk to the patient.”
本文關(guān)鍵字:
收藏本文到: Digg Live Bookmark Facebook 百度搜藏 新浪ViVi 365Key網(wǎng)摘 天極網(wǎng)摘 和訊網(wǎng)摘 POCO網(wǎng)摘 QQ書簽

  《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務(wù)咨詢: 美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢

我要評論:《心臟:磁共振來預(yù)測治療成功》
匿名發(fā)表 我的名字: Email: 驗證碼: 點(diǎn)擊可刷新
 
    
合作支持:中華醫(yī)學(xué)會 | 中華醫(yī)院管理學(xué)會 | 國家食品藥品監(jiān)督管理家用護(hù)理器械商城 | 國藥勵展展覽有限責(zé)任公 | 醫(yī)學(xué)裝備協(xié)會
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關(guān)于美迪 | 法律聲明 | 隱私保護(hù) | 網(wǎng)站地圖
把美迪網(wǎng)放進(jìn)收藏夾  把美迪醫(yī)療網(wǎng)介紹給我的朋友  給美迪醫(yī)療網(wǎng)留言
美迪醫(yī)療網(wǎng)廣告業(yè)務(wù)聯(lián)系:021-51601230 產(chǎn)品咨詢業(yè)務(wù)聯(lián)系:021-51601230 傳真:021-56532303    美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢
互聯(lián)網(wǎng)藥品信息服務(wù)許可證:(滬)-經(jīng)營性-2009-0003   中華人民共和國電信與信息服務(wù)業(yè)務(wù)經(jīng)營許可證:(滬)B2-20090029 滬ICP備14001091號-8
 
公安備案號 31010602000199 醫(yī)療器械經(jīng)營許可證: 滬靜藥監(jiān)械經(jīng)營許20210003號 第二類醫(yī)療器械經(jīng)營備案憑證: 滬靜藥監(jiān)械經(jīng)營備20220042號
營業(yè)執(zhí)照:統(tǒng)一社會信用代碼91310108676284138X互聯(lián)網(wǎng)藥品信息服務(wù)資格書:(滬)-非經(jīng)營性-2023-0081
消防排煙風(fēng)機(jī) 華創(chuàng)商務(wù)網(wǎng)
美迪醫(yī)療網(wǎng)廣告業(yè)務(wù)聯(lián)系:021-51601230  產(chǎn)品咨詢業(yè)務(wù)聯(lián)系:021-51601230 傳真:021-56532303   美迪醫(yī)療網(wǎng)產(chǎn)品咨詢 本QQ僅咨詢廣告和會員業(yè)務(wù),不咨詢產(chǎn)品和藥品等業(yè)務(wù)美迪醫(yī)療網(wǎng)推廣業(yè)務(wù)咨詢